BENITIONSClinical Trial Intelligence

Brain Health in Midlife

不适用 已完成 NCT06640842

适应症Brain Health, Gestational Hypertension, Alzheimer Disease, Dementia
分期不适用
申办方University of Kansas Medical Center
状态已完成
受试者人数24 人
干预(药物)A combination of various tests and biomarkers will be completed to understand the effect of hypertensive disorders of pregnancy on brain health in midlife.
开始日期2024年9月23日
完成日期2025年6月13日
结果公布日2026年7月14日

摘要

The purpose of this study is to learn if hypertensive disorders during pregnancy affects brain health in midlife.

Cardiometabolic Biomarkers - Glucose & Lipids

Baseline · mg/dL

Hypertensive Disorder of Pregnancy93.25 ± 15.71 mg/dL
Healthy Pregnancy94.50 ± 13.53 mg/dL
Hypertensive Disorder of Pregnancy170 ± 38.69 mg/dL
Healthy Pregnancy172.50 ± 28.27 mg/dL
Hypertensive Disorder of Pregnancy92.58 ± 32.81 mg/dL
Healthy Pregnancy132.42 ± 83.07 mg/dL

Cardiometabolic Biomarkers - Insulin

Baseline · uIU/mL

Hypertensive Disorder of Pregnancy7.44 ± 3.63 uIU/mL
Healthy Pregnancy14.13 ± 12.97 uIU/mL

Cardiometabolic Biomarkers - Hemoglobin A1C

Baseline · percentage of glycated hemoglobin

Hypertensive Disorder of Pregnancy5.72 ± 1.09 percentage of glycated hemoglobin
Healthy Pregnancy5.45 ± 0.34 percentage of glycated hemoglobin

在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文

同一适应症的其他试验

全部试验

本页整理自 ClinicalTrials.gov 的公开数据,不构成医疗建议,也不构成投资建议。请务必咨询专业医师。